Loading chart…
PRE-MARKET
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals.
Acutaas Chemicals Limited (ACUTAAS) is listed on the NSE in the Basic Materials sector, Specialty Chemicals industry. The ACUTAAS share price is ₹3,882.60 (+2.54% today), with a market capitalisation of ₹318B and a price-to-earnings (P/E) ratio of 72.7. MarketRipple tracks the ACUTAAS investment thesis, the ripple-chain impact of market events on Acutaas Chemicals Limited, and the Basic Materials sector outlook.
Open
₹3,901.00
High
₹3,955.00
Low
₹3,782.50
Prev. Close
₹3,786.60
52W High
₹4,045.30
52W Low
₹1,570.00
Day range
₹3,782.50–₹3,955.00
52-week range
₹1,570.00–₹4,045.30
Volume
441K
P/E
72.7
ROE
26.1%
D/E
0.02
Margin
27.6%
Acutaas Chemicals Limited (NSE: ACUTAAS) is currently trading at ₹3,882.60 (+2.54%).
Acutaas Chemicals Limited's market capitalization is ₹318B.
Acutaas Chemicals Limited's price-to-earnings (P/E) ratio is 72.7.
Acutaas Chemicals Limited operates in the Basic Materials sector (Specialty Chemicals).
Analyst consensus on Acutaas Chemicals Limited currently reads positive, based on 9 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.